Skip to main content
. 2017 Mar 9;44(6):950–959. doi: 10.1007/s00259-017-3665-9

Table 2.

PSA responses to the first, second and third therapies with 131I-MIP-1095

Any PSA response ≥25% PSA decline ≥50% PSA decline ≥75% PSA decline
1st therapy n = 32 (94.1%) n = 29 (85.3%) n = 24 (70.6%) n = 13 (38.2%)
2nd therapy n = 15 (65.2%) n = 13 (56.5%) n = 7 (30.4%) n = 2 (8.7%)
3rd therapy n = 1 (33.3%) n = 0 n = 0 n = 0